To develop a signature for prognosis prediction of BLCA, 19 genes (C1QTNF6, DAB2, ESD, FKBP10, GAD1, INHBA, LAMA2, LGALS3, MPPED1, OLFML3, PCOLCE, RASD1, RGS12, RUNX2, TIMP2, TMEM151A, TSSK1B, VAT1, and VEGFA) were obtained to build the risk model (Figures 3A, B). Here, RASD1 is linked to bladder transitional cell carcinoma.